COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,762 Articles (22,946 medRxiv, 8,816 bioRxiv)

Most recent first Previous |  Page 264: Articles 2631-2640  | Next

The risks of autoimmune- and inflammatory post-acute COVID-19 conditions: a network cohort study in six European countries, the US, and Korea
Burkard, T., Lopez-Guell, K., Catala, M., Burn, E., Delmestri, A., Khalid, S., Joedicke, A. M., Dedman, D., Oyinlola, J. O., Abellan, A., Perez Crespo, L., Mercade-Besora, N., Duarte-Salles, T., Prieto-Alhambra, D., Arinze, J., Mosseveld, M., Kolde, R., Melendez, J., Lopez-Blasco, R., Martinez, A., Valdivieso, B., Delseny, D., Mercier, G., Kim, C., Kim, J.-W., Kostka, K., Ramirez-Anguita, J. M., Mayer, M. A., Trinh, N. T., Nordeng, H. M., Paredes, R., Uuskula, A., Nishimura, A., Loste, C., Mateu, L., Xie, J.
10.1101/2024.05.15.24307344 — Posted: 2024-05-15
Clinical Course and Factors Associated With Hospital Admission and Mortality among Sars-Cov 2 Patients within Nairobi Metropolitan Area.
NJUGUNA, A. G., Wangombe, A. W., Walekhwa, M. N., Kamondo, D. K.
10.1101/2024.05.15.24307403 — Posted: 2024-05-15
Optimal timing of booster doses in a highly vaccinated population with minimal natural exposure to COVID-19
Conway, E., Walker, C., Lydeamore, M., Golding, N., Ryan, G., Mavec, D., Oates, J., Kabashima, G., Price, D. J., Shearer, F., Cromer, D., Davenport, M. P., McCaw, J., Eriksson, E. M., Hodgkin, P. D., Wu, L., Le, T. P., Baker, C. M., Mueller, I., McVernon, J.
10.1101/2024.05.14.24307386 — Posted: 2024-05-15
Decoding glycosylation potential from protein structure across human glycoproteins with a multi-view recurrent neural network
Kellman, B., Mariethoz, J., Zhang, Y., Shaul, S., Jeffris, M., Sandoval, D., Jeffris, M., Armingol, E., Bao, B., Lisacek, F., Bojar, D., Lewis, N.
10.1101/2024.05.15.594334 — Posted: 2024-05-15
Protein structure, a genetic encoding for glycosylation
Kellman, B., Sandoval, D., Zaytseva, O., Brock, K., Baboo, S., Nachmanson, D., Irvine, E., Armingol, E., Mih, N., Zhang, Y., Jeffris, M., Bartels, P., Nguyen, T., Tam, A., Gasman, S., Ilan, S., Shamie, I., Diedrich, J., Wang, X., van Woudenbergh, E., Altman, M., Aylward, A., Bao, B., Castro, A., Sorrentino, J., Chiang, A., Campbell, M., Bartsch, Y., Aguilar-Calvo, P., Sigurdson, C., Alter, G., Lauc, G., Yates, Y., Marks, D., Lisacek, F., Lewis, N.
10.1101/2024.05.15.594261 — Posted: 2024-05-15
The triple combination of Remdesivir (GS-441524), Molnupiravir and Ribavirin is highly efficient in inhibiting coronavirus replication in human nasal airway epithelial cell cultures and in a hamster infection model
Do, T. N. D., Abdelnabi, R., Boda, B., Constant, S., Neyts, J., Jochmans, D.
10.1101/2024.05.14.594200 — Posted: 2024-05-15
Assessing pH-dependent Conformational Changes in the Fusion Peptide Proximal Region of the SARS-CoV-2 spike glycoprotein
Stepanenko, D., Wang, Y., Simmerling, C.
10.1101/2024.05.15.594386 — Posted: 2024-05-15
Coming out of the ashes we rise: Experiences of culturally and linguistically diverse international nursing students at two Australian universities during the Covid-19 pandemic
Lim, E., Ng, L., Zhou, H., Nair, A., Kalembo, F.
10.1101/2024.05.13.24307209 — Posted: 2024-05-14
SAFETY AND IMMUNOGENICITY OF A PHH-1V BOOSTER DOSE AFTER DIFFERENT PRIME VACCINATION SCHEMES AGAINST COVID-19: PHASE III CLINICAL TRIAL FINAL RESULTS UP TO ONE YEAR
Natalini Martinez, S., Ramos, R., Navarro-Perez, J., Lopez, M. J., Vazquez, M. d. M., Molto, J., Munoz, P., Echave, J. M., Arribas, J. R., Alvarez, M., Arana-Arri, E., Calls, J., Otero-Romero, S., Scaglione, F., Bernad, L., Perez-Caballero, R., Prado, J. G., Esteban, I., Aurrecoechea, E., Pomarol, R., Plana, M., Soriano, A.
10.1101/2024.05.14.24307343 — Posted: 2024-05-14
SARS-CoV-2 Infection of Salivary Glands Predisposes to Oral Candidiasis
Alfaifi, A. A., Wang, T. W., Perez, P., Sultan, A. A., Meiller, T. F., Rock, P., Kleiner, D., Chertow, D. S., Hewitt, S., Gasmi, B., Stein, S., Ramelli, S., Martin, D., Warner, B., Jabra-Rizk, M. A.
10.1101/2024.05.13.593942 — Posted: 2024-05-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).